Yuhan Wang, Mengcan Wang, Beini Zhou, Wuriliga Yue, Ke Hu
{"title":"Obstructive sleep apnea, preserved ratio impaired spirometry (PRISm), and all-cause mortality: a community-based prospective study.","authors":"Yuhan Wang, Mengcan Wang, Beini Zhou, Wuriliga Yue, Ke Hu","doi":"10.1177/10815589251348913","DOIUrl":null,"url":null,"abstract":"<p><p>The association between obstructive sleep apnea (OSA) and preserved ratio impaired spirometry (PRISm) has not been well studied. This prospective cohort study enrolled 3408 adults aged 20-79 years without airflow obstruction. The median follow-up time was 11.8 years. Probable OSA (pOSA) was defined based on symptoms (snore, snort/stop breathing, sleepy) and was divided into a normal lung function group (FEV1 ≥ 80% predicted) and a PRISm group (FEV1 < 80% predicted) according to spirometry. Multivariable regression was used to analyze the association between pOSA and PRISm, and Cox regression and Kaplan-Meier analysis were used to assess the effects of pOSA alone, PRISm alone, and both on the risk of mortality. All analyses used survey weights. At baseline, 28.5% of participants presented with pOSA, and 11.4% had PRISm. Multivariable analysis showed an independent association between pOSA and PRISm (adjusted OR = 1.40, 95% CI 1.01-1.94, p = 0.04). Individuals with comorbid pOSA and PRISm had the highest risk of death (adjusted HR = 2.34, 95% CI 1.55-3.55) compared with individuals with PRISm alone (adjusted HR = 1.78, 95% CI 1.3-2.44), while individuals with pOSA alone were not significantly associated with death (adjusted p = 0.893). Kaplan-Meier analysis confirmed significant survival differences between the groups (p < 0.0001). Our results show that individuals with suspected OSA are associated with a higher prevalence of PRISm and individuals with comorbid OSA and PRISm have a higher risk of all-cause death. Although the limitations of the observational study do not allow us to determine causality, it emphasizes that the association between OSA and PRISm deserves further in-depth study.</p>","PeriodicalId":520677,"journal":{"name":"Journal of investigative medicine : the official publication of the American Federation for Clinical Research","volume":" ","pages":"10815589251348913"},"PeriodicalIF":2.0000,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of investigative medicine : the official publication of the American Federation for Clinical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/10815589251348913","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The association between obstructive sleep apnea (OSA) and preserved ratio impaired spirometry (PRISm) has not been well studied. This prospective cohort study enrolled 3408 adults aged 20-79 years without airflow obstruction. The median follow-up time was 11.8 years. Probable OSA (pOSA) was defined based on symptoms (snore, snort/stop breathing, sleepy) and was divided into a normal lung function group (FEV1 ≥ 80% predicted) and a PRISm group (FEV1 < 80% predicted) according to spirometry. Multivariable regression was used to analyze the association between pOSA and PRISm, and Cox regression and Kaplan-Meier analysis were used to assess the effects of pOSA alone, PRISm alone, and both on the risk of mortality. All analyses used survey weights. At baseline, 28.5% of participants presented with pOSA, and 11.4% had PRISm. Multivariable analysis showed an independent association between pOSA and PRISm (adjusted OR = 1.40, 95% CI 1.01-1.94, p = 0.04). Individuals with comorbid pOSA and PRISm had the highest risk of death (adjusted HR = 2.34, 95% CI 1.55-3.55) compared with individuals with PRISm alone (adjusted HR = 1.78, 95% CI 1.3-2.44), while individuals with pOSA alone were not significantly associated with death (adjusted p = 0.893). Kaplan-Meier analysis confirmed significant survival differences between the groups (p < 0.0001). Our results show that individuals with suspected OSA are associated with a higher prevalence of PRISm and individuals with comorbid OSA and PRISm have a higher risk of all-cause death. Although the limitations of the observational study do not allow us to determine causality, it emphasizes that the association between OSA and PRISm deserves further in-depth study.